Why Contraceptive Innovation?

Despite the availability of various contraceptive methods, more than 200 million women in developing countries want to avoid or delay pregnancy yet are not using an effective family planning method. For some of these women, access to contraception is limited. For others, currently available methods do not meet their needs or preferences or are unaffordable. Innovative solutions are needed in the areas of product development, registration, pricing, and introduction to address these barriers.

Join the exchange and become part of the solution!

Visit our resource library for additional information about the need for contraceptive innovation.


A one-stop shop for resources related to contraceptive research and development

The CTI Exchange offers resources about contraceptive research and development, including information about products currently in development, preclinical and clinical research, and opportunities for future investment. This easily searchable resource library also includes information about regulatory requirements, quality assurance standards, intellectual property, and product introduction strategies, as well as tools for advocacy.

View all resources


Featured resources and latest news from the Exchanges blog


New Resource Focuses on African Harmonization
The African Union's new Model Law on Medical Products Regulation provides a framework to ensure that life-saving drugs and technologies developed, made and distributed in Africa are safe, ef...

NICHD to Fund Multi-disciplinary Contraceptive Research
NICHD seeks to expand the scope of work of its funded contraception research centers to integrate biomedical product development with behavioral and social science research.

Keeping Male Contraceptive Research Front and Center
Novel approaches, identification of new genetic targets, and more expansive acceptability research could lead to development of new male contraceptives in our lifetime.

Calliope, the Contraceptive Pipeline Database
Calliope, the Contraceptive Pipeline Database, provides information on new and future contraceptive products, including long-acting and novel products currently only available in li...

A Sperm’s 88-Day Journey: Expanding Opportunities for Male Cont...
With today’s technological advancements, molecular biologists and medicinal chemists now target multiple points along a sperm’s 3-month circuitous journey -- not just the sperm-release p...

High-level Panel Reports on Access to Health Technologies
High-level United Nations panel calls for General Assembly special session to develop accountability framework that promotes innovation while ensuring access to critical health care technolo...

Grand Challenges Explorations #18 Targets Contraceptive Research
Two of the four topics in the Bill & Melinda Gates Foundation's Grand Challenges Explorations Round 18 Call for Concepts are of particular interest to contraceptive technology researchers.

Engaging Males in Family Planning – Disrupting the Status Quo
When men are well informed about the benefits of contraception, they can become active participants in the health and well-being of their partners and children.

WHO to Review Risk of HIV Acquisition with Hormonal Contraception
The World Health Organization will convene an expert group to assess its current guidance on use of hormonal contraception by women at risk of HIV acquisition given an updated systematic rev...

CDC Updates Contraceptive Use Recommendations
The U.S. Centers for Disease Control and Prevention (CDC) has updated two key guidance documents on contraceptive use.

Making New Male Contraceptives a Reality
Slow, steady progress is being made in male contraceptive research but important challenges still need to be addressed.

Genetic and Small Molecule Advances Bode Well for Male Contracept...
Recent advances suggest that development of a non-hormonal male contraceptive may be possible.


We want you to join the exchange!


The CTI Exchange looks to partners to help generate and share resources. Contact us with your ideas, materials, or questions, or sign up to receive more information. We also encourage you to provide your feedback